T he evolution of esophageal function testing has moved rapidly over the last 10 years along the continuum of manometric technique and bolus transit assessment. This has involved major improvements in manometry where the current state of the art is highresolution manometry with esophageal pressure topography. 1 Along similar lines, the evaluation of bolus transit has also evolved from a singular assessment of bolus transit during videofluoroscopy to a more comprehensive approach where intraluminal impedance monitoring can describe bolus transit in the context of a simultaneous pressure analysis to combine the strengths of both techniques. 2 However, these advances primarily represent modifications and improvements on existing technology and the assessment of esophageal function has not moved far beyond an assessment of contractile patterns and bolus movement.
Recently, a new technology has become available, the functional lumen imaging probe (FLIP), which focuses on measuring mechanical properties of the esophagus as opposed to contractile patterns and bolus transit. 3 The development of this techniques was based on previous concepts and techniques developed by Hans Gregerson and Satish Rao. 4 FLIP uses high-resolution impedance planimetry during volume-controlled distention to measure luminal cross-sectional area (CSA) along an axial plane. This is synchronized to a singular pressure measure within a fluid-filled bag ( Figure 1 ) and thus, allows for an assessment of luminal geometry and pressure akin to compliance measurement. This technique has been used to assess the mechanical properties of the esophageal wall and opening dynamics of the esophagogastric junction (EGJ) in various esophageal diseases. Whether this new information can lead to improvements in clinical outcome is just being explored and there seems to be promising results focused in achalasia and eosinophilic esophagitis (EoE).
This clinical practice update on FLIP reviews the methodology of the technique and the data supporting its clinical utility in specific esophageal disorders. The review is a summary of expert opinion in the field without a formal systematic review of evidence. 
Methodology and Technical Aspects
The FLIP consists of a 240-mm long, 3-mm outer diameter catheter with a balloon mounted on the distal end. The catheter contains 16 paired impedance planimetry electrodes within the balloon spaced at various intervals ranging from 4 mm to 1 cm based on the bag configuration and length (Figure 1 ). An infinitely compliant balloon of varying diameters based on the assessment required is filled with a conductive fluid from an 80-mL syringe housed and controlled from the Endo-FLIP system (Crospon, Galway, Ireland). Excitation electrodes at either end of the balloon emit a continuous low electric current and the voltage is measured across the paired impedance planimetry electrodes by leveraging Ohm's law to provide a measurement of CSA and volume at intervals based on excitation electrode spacing. A solidstate pressure transducer is located at the distal end of the bag and thus, a simultaneous measure of pressure is made and an assessment of distensibility of the esophageal body and/or EGJ can be performed. Multiple device sizes are commercially available with FLIP measurement segments of 6.0-16 cm (Table 1) . [5] [6] [7] [8] The FLIP is placed into the esophagus either transorally or transnasally in a sedated or awake patient. Most protocols are performed with the catheter placed orally during conscious sedation or while the patient is under general anesthesia in the operating room. The FLIP is positioned within the esophagus by identifying the waist-like constriction of the EGJ on the real-time, 3-dimensional geometric display at a low fill volume (typically 20-30 mL) (Figure 1 ). Alternatively, direct visualization can be used by passing the endoscope alongside of the FLIP catheter. Variations in FLIP study methods and protocols exist based on the disease state and the measurement of interest (Table 2 ). These differences are covered in the subsequent sections focused on specific esophageal disorders.
Data Analysis
The FLIP is indicated (and Food and Drug Administration-approved for use in the United States) for clinical use as a pressure and dimension measurement device, as an adjunctive test in patients with symptoms consistent with esophageal hypersensitivity and to estimate the size of a stoma produced by a gastric band. Thus, clinical applications for FLIP are varied and data analysis can be tailored to target the specific disease of interest.
During FLIP assessment, measurements of 16 CSA and pressure are simultaneously taken using a 10-Hz sampling rate. The 16 CSA measures are recorded at various intervals based on electrode spacing to assess the relationship between luminal CSA and distending (intrabag) pressure. In its most simple form, FLIP can be used real-time to assess the narrowest area along the 16 recording sites positioned within the anatomic zone of interest while measuring simultaneous pressure. This can be assessed visually using the 3-dimensional display that provides a color-spatial reference and a concomitant number measurement of the diameter (Figure 1 ). The distensibility index (DI) is the typical measure of sphincter distensibility and is calculated by dividing the median narrowest CSA (within the anatomic zone of interest) by the median intrabag pressure over a set timeframe (or distention volume). 5 The DI and narrowest diameter during distention can be derived from this real-time analysis; however, FLIP measurements are dynamic with CSA and pressure fluctuation occurring during a stable distention volume because of respiratory and vascular artifacts and the effect of both spontaneous and balloon distention-induced esophageal contraction. Thus, various methods using the FLIP Analytics software (Crospon) or other external software methods (eg, MatLAB, The Math Works, Natick, MA) have been developed to counteract these effects using various filtering techniques and analysis paradigms. [9] [10] [11] Given that impedance planimetry data are acquired in high resolution over a space-time domain, the diameter data at each axial location along the catheter can be expressed as a topography plot using interpolation and a color scale to depict diameter size ( Figure 2) . 9, 10 This is akin to the data presentation used in high-resolution manometry and represents a novel method to visualize diameter changes over time with simultaneous pressure during controlled volume distention. The benefits of FLIP topography are the ability to define EGJ distensibility and function while simultaneously obtaining information regarding the contractile activity and distensibility of the esophageal body. This approach has been used to better characterize the motor activity in the body of the esophagus in achalasia subtypes where patients were categorized based on 3 distinct body patterns that consisted of repetitive antegrade contractions, repetitive retrograde contractions, or absence of activity ( Figure 2 ).
12,13
Data analysis techniques have also been modified and refined in the assessment of disease activity in EoE ( Figure 3 ). The distensibility plateau is the metric of primary interest in EoE and represents the point of narrowest diameter (or CSA) along the esophagus that demonstrates resistance to further distention during an escalation in balloon pressure.
14 This is derived by plotting the narrowest CSA across the esophageal body as a function of pressure and has been shown to be substantially different between asymptomatic control subjects and EoE patients both with and without stricture. This analysis may also be hampered by catheter movement and esophageal contractility being misinterpreted as a fixed luminal narrowing and thus, various analysis approaches have been used, such as wavelet decomposition, maximal diameter, and FLIP Analytics software filtering. A recent study comparing these 3 approaches suggests that the maximal diameter approach using the maximal diameter attained at each axial location may be the most accurate. 11 Additionally, FLIP topography can also be used to assess areas of narrowing along the body over the entire study to assess the distensibility plateau.
There are limitations in the current analysis techniques because most require postacquisition processing and specialized programming using MatLAB and are thus not widely available. However, the manufacturer is developing real-time FLIP topography and analytics of maximal diameter in the future software updates.
Achalasia
A hallmark of achalasia is lower esophageal sphincter (LES) dysfunction and achalasia treatments target the resultant EGJ outflow obstruction; thus, FLIP seems well suited for evaluation of patients with achalasia.
Studies using FLIP have consistently demonstrated an abnormal reduced EGJ-DI (ie, more narrowed EGJ diameter at greater distending pressure) in treatmentnaive patients with achalasia. 6, 15, 16 Furthermore, studies assessing achalasia treatment response (eg, after pneumatic dilation or LES myotomy) have reported lower EGJ-DI in patients with poor symptomatic outcomes (particularly below a threshold of 2.8-2.9 mm 2 /mm Hg) than in patients with good symptomatic outcomes 6, 15 ; they also suggest that EGJ-DI may have a stronger association with symptoms and esophageal retention (per timed-barium esophagram) than manometric measures of LES pressures. FLIP may better characterize EGJ function because the degree of luminal opening is conceptually a more important determinant of bolus flow than LES relaxation. Additionally, evaluation of esophageal contractility (described in more detail later) with achalasia may also provide complementary clinical information to the standard achalasia assessment with esophageal manometry by further refining esophageal body contractile patterns and subtypes ( Figure 2B ). 12, 13 Intraoperative use of FLIP during laparoscopic Heller myotomy or per-oral endoscopic myotomy (POEM) also offers the ability to assess the LES myotomy in real-time. Several studies have demonstrated an immediate increase in EGJ-DI following POEM or Heller myotomy (associated with a slight decrease following fundoplasty creation). [17] [18] [19] [20] Furthermore, intraoperative FLIP may provide a method to tailor the myotomy with or without fundoplasty to help improve dysphagia (ie, avoid too low EGJ distensibility), while limiting gastroesophgeal reflux disease (GERD) (ie, avoid overly increasing EGJ distensibility). A recent multicenter study assessed the association with early clinical outcomes (median follow-up, 122 days) and retrospectively evaluated final intraoperative FLIP measures of 63 patients with achalasia treated with POEM. 19 They found a lower EGJ-CSA at a 30-mL fill volume of an 8-cm FLIP (but similar EGJ-CSA at 40 mL) in those with a poor symptomatic outcome (n ¼ 13) than those with a good outcome (n ¼ 50). EGJ-DI was numerically, but not statistically, lower among the poor outcome group at both 30-and 40-mL fill volumes. Another recent study reported that a final intraoperative EGJ-DI (at 40-mL distention volume with an 8-cm FLIP) of 4.5-8.5 mm 2 /mm Hg was less likely to have dysphagia or GERD symptoms at >6 months follow-up after POEM (n ¼ 21) or laparoscopic Heller myotomy (n ¼ 11). 21 Although additional study is needed to validate these findings in a prospective manner, FLIP offers significant promise to aid in the treatment of achalasia.
Additionally, esophageal dilatation balloons (incorporating a more rigid balloon material than the measurement FLIP balloons) are available (Table 1) . There is no intrabag pressure sensor included with the dilation balloons and thus, the diameter alone is used to target and follow dilation effect. 22 A recent study demonstrated the feasibility and clinical effectiveness of using the Eso-FLIP (Crospon) achalasia hydraulic dilation balloon (maximal diameter of 30 mm). 22 Because the EGJ can be identified with a waist on the real-time display to position the balloon, this device may allow for achalasia dilation to be performed without the concurrent use of fluoroscopy.
In conclusion, FLIP seems to be useful in the evaluation of achalasia and thus should be used to provide additive information beyond manometry in the management of achalasia.
Gastroesophageal Reflux Disease
Because EGJ incompetence may contribute to GERD pathophysiology in some patients, it is reasonable to suspect that FLIP may help identify increased EGJ distensibility (ie, greater EGJ diameters at lower distending pressures) in some patients with GERD. Results of studies, however, have been inconsistent. Initially, a study demonstrated greater EGJ-DIs among 20 symptomatic patients with GERD than 20 asymptomatic volunteers. 5 However, another study that compared patients with typical GERD symptoms (n ¼ 18) and 48-hour wireless esophageal pH monitoring with asymptomatic control subjects (n ¼ 18) found that patients with GERD actually had lower EGJ-DI than control subjects. 8 Furthermore, EGJ-DI did not differ between patients with normal (n ¼ 9) or abnormal (n ¼ 9) esophageal acid exposure time. Recently, a study evaluating patients with Barrett's esophagus with hiatal hernia !2 cm (n ¼ 23) reported that FLIP could generally identify hiatal hernia, measure both distensibility of LES and crural diaphragm components of the EGJ, and that the distensibility of the LES in hiatal hernia patients was greater than asymptomatic control subjects. 23 Although the diagnostic utility of FLIP in GERD may remain in question, further study may help evaluate physiologic components related to GERD pathophysiology.
Because patients with fundoplication seem to have reduced EGJ distensibility compared with control subjects, 5 FLIP may be a useful tool to aid antireflux procedures (eg, fundoplication). 24 Several studies demonstrated the feasibility of intraoperative FLIP use during fundoplication and a consistent reduction in EGJ distensibility immediately following fundoplication. 24, 25 Reduction in EGJ distensibility following transoral incisionless fundoplication has also been reported. 26, 27 A report of pooled results of intraoperative FLIP during laparoscopic Nissen fundoplication from 4 high-volume centers reported a mean final EGJ diameter of 6.1 mm (standard deviation, 1.4) and EGJ-DI of 1.6 mm 2 /mm Hg (standard deviation, 1.1), suggesting these as targets for fundoplication based on historically good outcomes from their centers; however, directly associated clinical outcomes were not reported. 24 In summary, the role of FLIP for physiologic evaluation and management in GERD remains appealing; however, the level of evidence is low and currently FLIP should not be used in routine GERD management. Future outcome studies are needed to substantiate the utility of FLIP in GERD and to develop metrics that predict severity and treatment response after antireflux procedures.
Eosinophilic Esophagitis
EoE is a chronic, immune-mediated disease of the esophagus characterized by esophageal symptoms (predominantly dysphagia/food impaction) and eosinophilic inflammation. 28 Chronic inflammation is thought to progress to fibrosis of the esophagus leading to luminal narrowing and a loss in mural compliance. 29 These remodeling consequences of EoE are the primary determinant of symptoms and are typically assessed by = Figure 2 . FLIP data analysis. Examples of data acquisition and analysis in an asymptomatic control subject (A) and a patient with achalasia (B). The pressure (red) recordings are depicted in the upper panel. Diameter data from each impedance planimerty channel is scaled from 5 to 30 mm and is interpolated and color coded on a hot/cold scale (small diameters are red/large diameters are blue) to generate FLIP topography akin to what is visualized during high-resolution manometry. In the asymptomatic control subject (A), real-time 3-dimensional images are depicted to show various points of interest using shape and color (small diameters are red/large diameters are blue) to highlight narrowing. Time point 1 illustrates the baseline with minimal pressure and balloon filling. Time points 2-4 represent propagation of a single antegrade contraction within the sequence of repetitive antegrade contractions where one can see the narrowing associated with contraction move distally within the 3D image and the propagating contraction on FLIP topography noted by the red color similar to peristalsis noted on high-resolution manometry. Time point 5 represents a period of quiescence at 60 mL with balloon diameters reaching the limits of the bag at 22 mm. In the patient with achalasia (B), time point 1 once again represents baseline with 5-mL filling. As the volume distention occurs with filling from 20 mL to 60 mL, the EGJ is visualized on the 3D images as a narrowing and low diameter. At time point 3, the EGJ initially opens at an intraballoon pressure of 24 mm Hg and the distensibility index is 1.0 mm 2 /mm Hg. At time point 4 with a 60-mL filling volume, the diameter is 12.5 mm and the pressure is 42 mm Hg with a distensibility index of 2.9, which is right at the cutoff value of 2.8 mm 2 /mm Hg for achalasia. The concomitant FLIP topography displays the narrowed zone at the EGJ that appears to remain relatively closed through most of the study and never opens to a level greater than 12.5 mm. In addition, the contractile activity in the body of the esophagus is erratic with both antegrade and retrograde contractions suggesting a motility disorder. means of endoscopy. 30 Unfortunately, endoscopic assessment of esophageal narrowing in EoE has substantial limitations in terms of accuracy when compared with fluoroscopic imaging. 31 FLIP assessment of the esophageal body in EoE allows for objective and accurate measurement of esophageal narrowing and mechanical properties of the esophageal body Measurement of a narrowest esophageal body CSA and corresponding intrabag pressure during step-wise volumetric distention with the FLIP positioned in the esophageal body allows identification of the distensibility plateau (Figure 3) . The predictive value of this assessment was reported in a study of patients with EoE using requirement for dilation therapy and risk of food impaction as endpoints. This study supported that a distensibility plateau <225 mm 2 (diameter w17 mm) was the only independent predictor (ie, not treatment type or eosinophil count, among others) of future food impaction. 32 Although the severity of endoscopically identified esophageal signs of remodeling (rings) is associated with esophageal distensibility, FLIP offers significantly greater accuracy and precision in estimating the effects of remodeling. 33 Although FLIP seems to have significant value for the assessment of disease severity and clinically relevant symptom outcomes in EoE, the identification of the narrowest portion of the esophageal body used in the calculation of the distensibility plateau is often technically challenging in the setting of esophageal contractions. Thus, postprocessing the FLIP data using software programs to filter out the contractionassociated changes in esophageal luminal diameter is necessary. [9] [10] [11] Software enhancements are being developed that improve the current analysis paradigms and should broaden the clinical utility of FLIP in the evaluation of EoE.
In summary, FLIP seems to be uniquely suited to assess the mechanical properties of the esophageal wall in EoE. Nonetheless, current recommendations are limited by the low level of evidence and lack of generalized availability of the analysis paradigms. Thus, one could consider performing FLIP in routine clinical management of EoE if the analysis expertise is available. Further outcome studies that validate the distensibility plateau threshold and further refinements in software analyses to make this methodology more generalizable are important.
Other Indications/Future Directions
Although distention-mediated peristalsis observed on FLIP can make assessment of passive mechanical properties slightly more complex, the information within these motor responses may be helpful in evaluating esophageal function. Serially spaced diameter changes along the axial length of the balloon that are recorded by FLIP can be used to define contractile activity similar to high-resolution manometry. 12 A recent study comparing data acquired during a FLIP assessment during sedated endoscopy and standard high-resolution manometry suggests that FLIP can accurately diagnose achalasia and may be complementary to manometry in further refining the diagnosis of functional dysphagia (normal endoscopy/normal or borderline manometry). 13 Applying this as a tool to assess hypersensitivity in a barostat mode application is also appealing, but currently balloon distention studies are relegated to specialized centers.
The EndoFLIP is also being used to assess opening dynamics and mechanical properties of other anatomic zones of interest. Data have been reported in the upper esophageal sphincter 34 and there is also great interest in studying the pylorus in normal rhythm gastroparetic patients and anal-rectal function in patients with constipation and incontinence. 35 Lastly, the technique is still being assessed for its ability to tailor bariatric procedures and currently it is approved by the Food and Drug Administration for this indication.
Conclusions
The FLIP offers an innovative method that enhances the assessment of esophageal function in various diseases. Although the strongest data seem to be focused on the management of achalasia, emerging evidence supports the clinical relevance of FLIP in the assessment of disease severity and as an outcome measure in EoE intervention trials. Ongoing studies are evaluating the applications of FLIP to GERD interventions targeting the EGJ and other foregut disorders. More work is needed, however, which focuses on optimizing data analysis, standardizing protocols, and defining outcome metrics before the widespread adoption into general clinical practice.
